CANY
RGEN icon

Caxton Associates (New York)’s Repligen RGEN Stock Holding History

Caxton Associates (New York)’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,027
Closed -$205K – 576
2021
Q2 		$205K Buy
+1,027
New +$199K 0.02% 415
2020
Q2 		– Sell
-6,088
Closed -$588K – 593
2020
Q1 		$588K Buy
+6,088
New +$588K 0.11% 127

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Caxton Associates (New York)'s RGEN Position: Q3 2021 in Review

Caxton Associates (New York) sold out of Repligen (RGEN) in Q3 2021, closing a stake of 1,027 shares — an estimated $205K sold.

Caxton Associates (New York) first reported a position in RGEN in Q1 2020 and held it in 2 quarters. The position peaked at $588K in Q1 2020. 479 funds tracked by Wall St. Rank hold RGEN as of Q3 2021.

  • Caxton Associates (New York) reported no remaining Repligen position as of Q3 2021 after selling out during the quarter.
  • Caxton Associates (New York) sold 1,027 Repligen shares in Q3 2021, an estimated $205K.
  • Caxton Associates (New York) first reported a position in Repligen in Q1 2020 and held it in 2 quarters.
  • Caxton Associates (New York)'s Repligen position peaked at $588K in Q1 2020.
  • 479 funds tracked by Wall St. Rank held Repligen as of Q3 2021.

Based on Caxton Associates (New York)'s 13F filing for Q3 2021, filed 15 Nov 2021.